Prot #HCRN GU16-260: NU G17U11: Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma (BMS CA209-669)

Project: Research project

Project Details

StatusActive
Effective start/end date11/21/17 → 11/21/23

Funding

  • Hoosier Cancer Research Network, Inc. (Prot #HCRN GU16-260)
  • Georgetown University (Prot #HCRN GU16-260)